Butterfly Network Inc
Change company Symbol lookup
Select an option...
BFLY Butterfly Network Inc
YALA Yalla Group Ltd
SEER Seer Inc
ITCI Intra-Cellular Therapies Inc
VZ Verizon Communications Inc
TISI Team Inc
PRTK Paratek Pharmaceuticals Inc
KIRY Kiewit Royalty Trust
OCAXW OCA Acquisition Equity Warrant Exp 14 Jan 2026 *W EXP 01/31/2028
ABBV Abbvie Inc
Go

Company profile

Butterfly Network, Inc., formerly Longview Acquisition Corp., is a digital health company. The Company is principally engaged in offering medical imaging system, Butterfly iQ. The Butterfly iQ is a handheld, single probe, whole-body ultrasound system, which uses semiconductor technology. The Company's products are powered by its Ultrasound-on-Chip technology, which is an ultrasound transducer that can perform whole-body imaging. Its ultrasound system is comprised of both hardware and software solutions designed to make ultrasound imaging accessible to all healthcare practitioners, including nurses, midwives and ultimately patients directly. Butterfly iQ is commercially available in approximately 20 countries, including the United States, Canada, Australia, New Zealand and Europe. The Company also has an eCommerce Website through which it sells its Butterfly iQ+ to healthcare practitioners. Its Butterfly iQ+ connects to a smart phone or tablet to perform ultrasound scans.

Price
Delayed
$7.65
Day's Change
0.18 (2.41%)
Bid
--
Ask
--
B/A Size
--
Day's High
7.67
Day's Low
7.64
Volume
141,196

Bristol Myers Squibb Co. Stock Falls Friday, Underperforms Market

4:41 pm ET October 8, 2021 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Bristol Myers Squibb Co. (BMY) shed 2.97% to $57.26 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.19% to 4,391.34 and Dow Jones Industrial Average falling 0.03% to 34,746.25. This was the stock's second consecutive day of losses. Bristol Myers Squibb Co. closed $12.49 short of its 52-week high ($69.75), which the company achieved on August 23rd.

The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson (JNJ) fell 0.25% to $160.93, Merck & Co. Inc. (MRK) fell 1.60% to $80.63, and Pfizer Inc. (PFE) fell 0.68% to $42.45. Trading volume (27.2 M) eclipsed its 50-day average volume of 8.8 M.

Data source: Dow Jones Market Data, FactSet. Data compiled October 8, 2021.

-MarketWatch Automation

	

(END) Dow Jones Newswires

October 08, 2021 16:41 ET (20:41 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.